Adenocarcinoma — Trials

Adenocarcinoma — Trials · CancerIndex

Clinical trials

Registered studies

9,703 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 2,753
Recruiting: 1,520
Ph III recruiting: 168
Growth YoY: +6.8%
Industry share: 23%
Top sponsor: National Cancer Institute (NCI)
Termination share: 36.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,319)

clinicaltrialsPublishedShowing 1,701–1,750 of 1,898 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05019690	Apatinib Combined with Albumin-Bound Paclitaxel for Treatment of Advanced Triple Negative Breast Cancer	recruiting	Phase 1 / Phase 2	29	Fujian Cancer HospitalOTHER_GOV	1	Sep 19, 2024	clinicaltrials
NCT05830812	Improving the Intraoperative Diagnosis Accuracy of Invasiveness for Small-sized Lung Adenocarcinoma	recruiting	—	3,000	Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyOTHER	1